<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The following on <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPIs</z:chebi>) and chemoprevention in relation to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> includes commentaries on 48-h pH monitoring, pH-impedence, <z:chebi fb="0" ids="3098">bile acid</z:chebi> testing, <z:e sem="disease" ids="C0013395" disease_type="Disease or Syndrome" abbrv="">dyspepsia</z:e>, long/short segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery <z:chebi fb="4" ids="53266">PPIs</z:chebi>, immediate-release <z:chebi fb="4" ids="53266">PPIs</z:chebi>, long-term <z:chebi fb="4" ids="53266">PPI</z:chebi> use, prokinetic agents, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:chebi fb="0" ids="2972">baclofen</z:chebi>, nocturnal acid breakthrough, <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>), and new <z:chebi fb="4" ids="53266">PPIs</z:chebi> </plain></SENT>
</text></document>